Gutierrez-Esteinou Rolando 4
4 · ATAI Life Sciences N.V. · Filed Dec 28, 2021
Insider Transaction Report
Form 4
Gutierrez-Esteinou Rolando
Chief Medical Officer
Transactions
- Award
Stock Option
2021-12-24+325,000→ 325,000 totalExercise: $7.72Exp: 2031-12-23→ Common Shares (325,000 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the underlying shares on December 24, 2022 and in 36 equal monthly installments thereafter.